LeadIQ logo
Learn more at LeadIQ.com

Insights

Innovative focus ObsEva specializes in developing novel therapeutics for women’s reproductive health and pregnancy, presenting opportunities for partnerships in groundbreaking women’s health solutions.

Recent Leadership Change The appointment of a new CEO in May 2023 indicates a strategic shift or expansion focus, which can open doors for collaboration or consulting opportunities with decision-makers.

Strategic Funding With $75 million in funding and investments from prominent firms like Novo Holdings and Sofinnova Ventures, ObsEva demonstrates strong financial backing, signaling potential for scalable partnerships or clinical collaborations.

Market Positioning ObsEva’s focus on preterm labor and reproductive therapeutics aligns with growing demand in women’s health markets, making it a promising partner for companies seeking to expand into this niche.

Limited Revenue,High Potential While current revenue is below one million dollars, the company’s stage and investment levels suggest significant growth potential, ideal for early-stage collaborations or investor engagement in innovative women’s health technologies.

Similar companies to ObsEva SA

ObsEva SA Tech Stack

ObsEva SA uses 8 technology products and services including WordPress, Google Fonts API, Reveal.js, and more. Explore ObsEva SA's tech stack below.

  • WordPress
    Content Management System
  • Google Fonts API
    Font Scripts
  • Reveal.js
    Javascript Frameworks
  • jQuery UI
    Javascript Libraries
  • Google Analytics
    Web Analytics
  • Yii
    Web Frameworks
  • Understrap
    Web Platform Extensions
  • Apache HTTP Server
    Web Servers

Media & News

ObsEva SA's Email Address Formats

ObsEva SA uses at least 2 format(s):
ObsEva SA Email FormatsExamplePercentage
First.Last@obseva.chJohn.Doe@obseva.ch
81%
Last@obseva.chDoe@obseva.ch
19%
First.Last@obseva.comJohn.Doe@obseva.com
98%
Last.First@obseva.comDoe.John@obseva.com
2%

Frequently Asked Questions

Where is ObsEva SA's headquarters located?

Minus sign iconPlus sign iconObsEva SA's main headquarters is located at Plan-les-ouates, Geneva 1228 Switzerland. The company has employees across 2 continents, including EuropeNorth America.

What is ObsEva SA's stock symbol?

Minus sign iconPlus sign iconObsEva SA is a publicly traded company; the company's stock symbol is OBSVF.

What is ObsEva SA's official website and social media links?

Minus sign iconPlus sign iconObsEva SA's official website is obseva.com and has social profiles on LinkedIn.

What is ObsEva SA's SIC code NAICS code?

Minus sign iconPlus sign iconObsEva SA's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does ObsEva SA have currently?

Minus sign iconPlus sign iconAs of February 2026, ObsEva SA has approximately 12 employees across 2 continents, including EuropeNorth America. Key team members include Vice President Chemistry, Manufacturing And Control: J. P.Board Member & Executive Consultant: L. M.Regulatory Affairs Associate: B. C.. Explore ObsEva SA's employee directory with LeadIQ.

What industry does ObsEva SA belong to?

Minus sign iconPlus sign iconObsEva SA operates in the Biotechnology Research industry.

What technology does ObsEva SA use?

Minus sign iconPlus sign iconObsEva SA's tech stack includes WordPressGoogle Fonts APIReveal.jsjQuery UIGoogle AnalyticsYiiUnderstrapApache HTTP Server.

What is ObsEva SA's email format?

Minus sign iconPlus sign iconObsEva SA's email format typically follows the pattern of First.Last@obseva.ch. Find more ObsEva SA email formats with LeadIQ.

How much funding has ObsEva SA raised to date?

Minus sign iconPlus sign icon As of February 2026, ObsEva SA has raised $75M in funding. The last funding round occurred on Aug 08, 2019 for $75M.

When was ObsEva SA founded?

Minus sign iconPlus sign iconObsEva SA was founded in 2012.

ObsEva SA

Biotechnology ResearchGeneva, Switzerland11-50 Employees

Innovating Women’s Reproductive Health and Pregnancy Therapeutics

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy.

For more information, please visit www.ObsEva.com.

Section iconCompany Overview

Headquarters
Plan-les-ouates, Geneva 1228 Switzerland
Website
obseva.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
OBSVF
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
11-50

Section iconMedia & News

Section iconFunding & Financials

  • $75M

    ObsEva SA has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Aug 08, 2019 in the amount of $75M.

  • $1M

    ObsEva SA's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $75M

    ObsEva SA has raised a total of $75M of funding over 5 rounds. Their latest funding round was raised on Aug 08, 2019 in the amount of $75M.

  • $1M

    ObsEva SA's revenue is estimated to be in the range of $1M

Company Leadership

  • Stylized image of a person
    J. P.
    Vice President Chemistry, Manufacturing And Control
    Phone icon
    Mobile Phone
  • Stylized image of a person
    L. M.
    Board Member & Executive Consultant
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. C.
    Regulatory Affairs Associate
    Phone icon
    Mobile Phone

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.